Dr Kelly Loffler
B. Health Sc., B. Sc.(Hons), Ph.D.
Kelly completed a PhD at the Institute for Molecular Bioscience, University of Queensland, studying ovarian developmental biology.
She has since worked in Sweden at the University of Umeå, and at QIMR Berghofer Medical Research Institute, and has expertise in cell biology and extensive experience in development and analysis of animal models of development and disease, relevant to diabetes and pancreatic endocrine cancer. In the Surgical Oncology research group at the University of Queensland School of Medicine, Dr Loffler worked with clinicians in clinically oriented cancer research including local tissue banks and multi-centre trials, and was responsible for establishment of xenograft models of oesophageal cancer.
Dr Loffler joined AISH in 2016 to work on analyses of data from the SAVE (Sleep Apnea and cardioVascular Endpoints) trial and its substudies. Her primary interests are in metabolic and biomarker substudies, examining the cardiovascular risks associated with obstructive sleep apnea.